Surgery Partners, Inc. (SGRY)

Surgery Partners Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Net Income	-11.9	-54.6	-81.2	-155.6	-110.5
Depreciation & Amortization	153.3	149.6	137.9	134.2	116.5
Share-Based Compensation	17.7	18.4	17.4	13.2	10.2
Other Operating Activities	134.7	45.4	2.7	215.6	77.6
Operating Cash Flow	293.8	158.8	87.1	246.9	129.5
Operating Cash Flow Growth	85.01%	82.32%	-64.72%	90.66%	-10.44%
Capital Expenditures	-63	-67.7	-51.6	15.6	-56
Acquisitions	-80	-146.4	-285.8	-104.6	-13.8
Change in Investments	-48.9	-82.3	5.4	0	-15.2
Other Investing Activities	-33.7	-11.5	0.3	0.6	-0.2
Investing Cash Flow	-225.6	-307.9	-331.7	-88.4	-85.2
Share Issuance / Repurchase	0	857.7	554.2	0	0
Debt Issued / Paid	-4.8	-655.5	-55.5	204.6	-10.6
Other Financing Activities	-150.4	-160.1	-182.4	-137.9	-125.3
Financing Cash Flow	-155.2	42.1	316.3	66.7	-135.9
Net Cash Flow	-87	-107	71.7	225.2	-91.6
Free Cash Flow	230.8	91.1	35.5	262.5	73.5
Free Cash Flow Growth	153.35%	156.62%	-86.48%	257.14%	-40.73%
Free Cash Flow Margin	8.41%	3.59%	1.60%	14.11%	4.01%
Free Cash Flow Per Share	1.84	0.99	0.49	5.38	1.52

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).